Standardized pharmacological response tests are important and established diagnostic tools in the field of neurology. However, regarding therapeutic responses to intravenous immunoglobulins (IVIg) in CIDP, neither a definition of therapeutic response has been established, nor a response test has been suggested so far. Here we suggest a practical clinical approach which is supported by current literature in the field. An established standardized IVIg response test could avoid prolonged therapy without benefit for the patient and ensure a timely therapy switch or treatment escalation if required. This approach would also be advantageous due to the global scarcity of plasma derivatives as a human resource and could be the foundation to be adjusted and improved by subsequent studies.

• Klíčová slova
• CIDP, dosing, efficacy, intravenous immunoglobulin, therapy,
• MeSH
• chronická zánětlivá demyelinizační polyneuropatie * terapie   MeSH
• intravenózní imunoglobuliny terapeutické užití   MeSH
• intravenózní podání MeSH
• lidé MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• Názvy látek
• intravenózní imunoglobuliny MeSH